Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma

Gulsun Erdag, Sinchita Roy Chowdhuri, Patricia Fetsch, Dana Erickson, Marybeth S. Hughes, Armando C. Filie

Research output: Contribution to journalArticle

Abstract

The diagnosis of melanoma can be challenging, especially in metastatic lesions, due to the ability of melanoma cells to morphologically mimic carcinoma, sarcoma and even lymphoma cells. Moreover, melanomas can exhibit negative immunostaining for the melanoma markers HMB-45 and MART-1/Melan-A, often used in the diagnosis of this tumor. KBA.62 is a recently described antibody that reacts with benign and malignant melanocytic proliferations. In this study, we report our experience with KBA.62 and S100 protein immunostaining in the diagnosis of metastatic melanoma on fine-needle aspiration and effusion samples. We reviewed 60 cytology samples from 58 patients with metastatic melanoma. Our results showed that KBA.62 stained 75% of the cases and S100 protein 87% of the cases. KBA.62 and S100 protein stained the majority of metastatic melanomas that were negative for HMB-45 and MART-1; KBA.62 stained 73% of the cases and S100 protein 73% of the cases. The majority (85%) of the cases negative for HMB-45 and MART-1 were positive for KBA.62 and/or S100 protein. Additionally, we also observed that KBA.62 staining was positive in the majority of epithelioid and spindle cell type melanoma cells. In conclusion, the performances of KBA.62 and S100 protein were similar and both markers are useful in the diagnosis of metastatic melanoma in cytology material, especially when the tumor cells lack expression of HMB-45 and MART-1.

Original languageEnglish (US)
Pages (from-to)847-851
Number of pages5
JournalDiagnostic Cytopathology
Volume41
Issue number10
DOIs
StatePublished - Oct 2013
Externally publishedYes

Fingerprint

S100 Proteins
Melanoma
Cell Biology
MART-1 Antigen
Epithelioid Cells
Fine Needle Biopsy
Sarcoma
Lymphoma
Neoplasms
Staining and Labeling
Carcinoma
Antibodies

Keywords

  • cytology
  • immunocytochemistry/immunohistochemistry
  • KBA.62
  • melanoma
  • S100 protein

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Erdag, G., Chowdhuri, S. R., Fetsch, P., Erickson, D., Hughes, M. S., & Filie, A. C. (2013). Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma. Diagnostic Cytopathology, 41(10), 847-851. https://doi.org/10.1002/dc.22948

Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma. / Erdag, Gulsun; Chowdhuri, Sinchita Roy; Fetsch, Patricia; Erickson, Dana; Hughes, Marybeth S.; Filie, Armando C.

In: Diagnostic Cytopathology, Vol. 41, No. 10, 10.2013, p. 847-851.

Research output: Contribution to journalArticle

Erdag, G, Chowdhuri, SR, Fetsch, P, Erickson, D, Hughes, MS & Filie, AC 2013, 'Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma', Diagnostic Cytopathology, vol. 41, no. 10, pp. 847-851. https://doi.org/10.1002/dc.22948
Erdag, Gulsun ; Chowdhuri, Sinchita Roy ; Fetsch, Patricia ; Erickson, Dana ; Hughes, Marybeth S. ; Filie, Armando C. / Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma. In: Diagnostic Cytopathology. 2013 ; Vol. 41, No. 10. pp. 847-851.
@article{9ad3064738df4129bffd7c5fc3520327,
title = "Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma",
abstract = "The diagnosis of melanoma can be challenging, especially in metastatic lesions, due to the ability of melanoma cells to morphologically mimic carcinoma, sarcoma and even lymphoma cells. Moreover, melanomas can exhibit negative immunostaining for the melanoma markers HMB-45 and MART-1/Melan-A, often used in the diagnosis of this tumor. KBA.62 is a recently described antibody that reacts with benign and malignant melanocytic proliferations. In this study, we report our experience with KBA.62 and S100 protein immunostaining in the diagnosis of metastatic melanoma on fine-needle aspiration and effusion samples. We reviewed 60 cytology samples from 58 patients with metastatic melanoma. Our results showed that KBA.62 stained 75{\%} of the cases and S100 protein 87{\%} of the cases. KBA.62 and S100 protein stained the majority of metastatic melanomas that were negative for HMB-45 and MART-1; KBA.62 stained 73{\%} of the cases and S100 protein 73{\%} of the cases. The majority (85{\%}) of the cases negative for HMB-45 and MART-1 were positive for KBA.62 and/or S100 protein. Additionally, we also observed that KBA.62 staining was positive in the majority of epithelioid and spindle cell type melanoma cells. In conclusion, the performances of KBA.62 and S100 protein were similar and both markers are useful in the diagnosis of metastatic melanoma in cytology material, especially when the tumor cells lack expression of HMB-45 and MART-1.",
keywords = "cytology, immunocytochemistry/immunohistochemistry, KBA.62, melanoma, S100 protein",
author = "Gulsun Erdag and Chowdhuri, {Sinchita Roy} and Patricia Fetsch and Dana Erickson and Hughes, {Marybeth S.} and Filie, {Armando C.}",
year = "2013",
month = "10",
doi = "10.1002/dc.22948",
language = "English (US)",
volume = "41",
pages = "847--851",
journal = "Diagnostic Cytopathology",
issn = "8755-1039",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma

AU - Erdag, Gulsun

AU - Chowdhuri, Sinchita Roy

AU - Fetsch, Patricia

AU - Erickson, Dana

AU - Hughes, Marybeth S.

AU - Filie, Armando C.

PY - 2013/10

Y1 - 2013/10

N2 - The diagnosis of melanoma can be challenging, especially in metastatic lesions, due to the ability of melanoma cells to morphologically mimic carcinoma, sarcoma and even lymphoma cells. Moreover, melanomas can exhibit negative immunostaining for the melanoma markers HMB-45 and MART-1/Melan-A, often used in the diagnosis of this tumor. KBA.62 is a recently described antibody that reacts with benign and malignant melanocytic proliferations. In this study, we report our experience with KBA.62 and S100 protein immunostaining in the diagnosis of metastatic melanoma on fine-needle aspiration and effusion samples. We reviewed 60 cytology samples from 58 patients with metastatic melanoma. Our results showed that KBA.62 stained 75% of the cases and S100 protein 87% of the cases. KBA.62 and S100 protein stained the majority of metastatic melanomas that were negative for HMB-45 and MART-1; KBA.62 stained 73% of the cases and S100 protein 73% of the cases. The majority (85%) of the cases negative for HMB-45 and MART-1 were positive for KBA.62 and/or S100 protein. Additionally, we also observed that KBA.62 staining was positive in the majority of epithelioid and spindle cell type melanoma cells. In conclusion, the performances of KBA.62 and S100 protein were similar and both markers are useful in the diagnosis of metastatic melanoma in cytology material, especially when the tumor cells lack expression of HMB-45 and MART-1.

AB - The diagnosis of melanoma can be challenging, especially in metastatic lesions, due to the ability of melanoma cells to morphologically mimic carcinoma, sarcoma and even lymphoma cells. Moreover, melanomas can exhibit negative immunostaining for the melanoma markers HMB-45 and MART-1/Melan-A, often used in the diagnosis of this tumor. KBA.62 is a recently described antibody that reacts with benign and malignant melanocytic proliferations. In this study, we report our experience with KBA.62 and S100 protein immunostaining in the diagnosis of metastatic melanoma on fine-needle aspiration and effusion samples. We reviewed 60 cytology samples from 58 patients with metastatic melanoma. Our results showed that KBA.62 stained 75% of the cases and S100 protein 87% of the cases. KBA.62 and S100 protein stained the majority of metastatic melanomas that were negative for HMB-45 and MART-1; KBA.62 stained 73% of the cases and S100 protein 73% of the cases. The majority (85%) of the cases negative for HMB-45 and MART-1 were positive for KBA.62 and/or S100 protein. Additionally, we also observed that KBA.62 staining was positive in the majority of epithelioid and spindle cell type melanoma cells. In conclusion, the performances of KBA.62 and S100 protein were similar and both markers are useful in the diagnosis of metastatic melanoma in cytology material, especially when the tumor cells lack expression of HMB-45 and MART-1.

KW - cytology

KW - immunocytochemistry/immunohistochemistry

KW - KBA.62

KW - melanoma

KW - S100 protein

UR - http://www.scopus.com/inward/record.url?scp=84885019474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885019474&partnerID=8YFLogxK

U2 - 10.1002/dc.22948

DO - 10.1002/dc.22948

M3 - Article

C2 - 23554410

AN - SCOPUS:84885019474

VL - 41

SP - 847

EP - 851

JO - Diagnostic Cytopathology

JF - Diagnostic Cytopathology

SN - 8755-1039

IS - 10

ER -